Optimisation of individual cardiovascular risk assessment in a German coronary artery disease cohort using a commercial test for genetic polymorphisms - a pilot study.
Jona B KrohnClemens NeubauerSimon FischerChristian OberkaninsHugo A KatusChristian A GleissnerPublished in: Acta cardiologica (2022)
Commercially available assays for genetic polymorphisms may provide valuable information on individual genetic cardiovascular risk, potentially guiding future primary and/or secondary preventative therapies for coronary artery disease.
Keyphrases
- coronary artery disease
- risk assessment
- percutaneous coronary intervention
- coronary artery bypass grafting
- cardiovascular events
- high throughput
- current status
- human health
- heavy metals
- genome wide
- health information
- aortic stenosis
- copy number
- heart failure
- dna methylation
- climate change
- acute coronary syndrome
- single cell